Investigational drug · Phase 3
DIT112
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Moderate Pain, Severe Pain.
Phase 3Last checked: Nov 19, 2026Latest source record: Feb 20, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "DIT112"
First trial start
2025
Feb 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
- EMS1
All registered trials by phase
Every ClinicalTrials.gov drug study naming "DIT112", any sponsor or status.
Conditions studied
As listed on its trial records.
- Moderate Pain
- Severe Pain
Approved drugs for the same conditions: Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "DIT112" as an intervention, largest first.
- Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third MolarsPivotal-lookingNot yet recruiting
EMSIndustry
NCT06237231 · 252 participants (planned) · Start Feb 15, 2025 · Primary completion Mar 15, 2025
Drug: DIT112; DIPYRONE and 4 more · For: Moderate Pain; Severe Pain
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Moderate Pain
- DIPYRONEPhase 32 trials
EMS · Moderate Pain, Severe Pain, Common Cold/Flu
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.